Airfinity named among Bloomberg’s UK Startups to Watch 2023

Posted on Oct 24, 2023

Airfinity is delighted to announce its inclusion in Bloomberg’s UK Startups to Watch 2023.

The inaugural Bloomberg’s UK Startups to Watch canvassed the UK to find 25 startups that represent the diversity and innovation of the country's startup scene.

Bloomberg looked for the most innovative UK businesses to feature in the list. It wanted to hear about companies that are growing fast, working on something truly unique and come from a diverse group of founders from all over the UK.

Airfinity has been featured as a first of its kind disease forecasting company. We aim to predict disease outbreaks in the same way the weather, travel and financial markets are forecast.

At the forefront of innovation in life sciences, Airfinity tracks, predicts and simulates population level disease outcomes in real time. Our aim is to use data to help leaders make better informed decisions that can increase the global life span. 

Our teams built the world's first dedicated COVID-19 health analytics and intelligence platform in 2020, today we have built on this expertise and now cover over 150 diseases, including noncommunicable diseases (NCDs) across the cardiovascular space.

Airfinity’s CEO and founder Rasmus Bech Hansen says, “I am delighted that our work has been recognised by Bloomberg News. 

“The pandemic accelerated scientific innovation at a speed never seen before, now a new generation of medicines and diagnostics has the potential to transform modern healthcare.

“Data and analytics is central to implementing new pre-emptive innovations in health systems around the world. We believe our work is pivotal for the future of global public health.”

The full list of 25 companies will be unveiled today at the Bloomberg Technology Summit in London.

Bloomberg editors considered a number of criteria when assessing the entries including: the scope of the problem they're tackling, creativity of ideas, the traction they're getting with investors and customers, and their commitment to diversity.

More Insights From Airfinity

Introducing Airfinity Biorisk: Risk Surveillance and Analytics for 160+ Infectious Diseases

Oct 10, 2022

18 million monkeypox vaccines needed to protect most at risk, 85 million to protect wider gay community and health workers

Aug 25, 2022

Sales of COVID-19 antiviral pill Paxlovid to leap frog Merck’s competitor Molnupiravir

Jul 25, 2022

COVID-19 vaccines sales to bounce back with new jabs taking a fifth of the 2022 market

Jul 15, 2022

AstraZeneca and Pfizer/BioNTech saved over 12 million lives in the first year of vaccination

Jul 13, 2022

Global wastage of COVID-19 vaccines could be 1.1 billion doses

Jul 11, 2022